This event, sponsored by EMBRACE (Ending Metastatic Breast Cancer for Everyone), was held on October 18, 2014. This yearly forum is open to all patients with metastatic or advanced breast cancer, and their families.
Webcast, Part 1What's new in metastatic breast cancer and clinical trialsQuestion and answer session with experts
Slideshare presentation on Advances and Relevant Clinical Trials in HER2+ Metastatic Breast Cancer
Slideshare presentation on The Latest Research and Clinical Trials for ER+ and Triple-Negative Breast Cancer
Webcast, Part 2Pain and symptom management with integrative therapies
Slideshare presentation on Integrative Oncology and Breast Cancer
Webcast, Part 3Genomic medicine
Slideshare presentation on Breast Cancer Genomics and Precision Cancer Medicine
Webcast, Part 4Resources for metastatic breast cancer patients
Webcast, Part 1
Slideshare presentation on ER Positive and Triple-Negative Breast Cancer
Slideshare presentation on Phase I Clinical Trials
Webcast, Part 2
Slideshare presentation on Coping with Advanced Breast Cancer: A Roller Coaster of Emotions
Slideshare presentation on Acupuncture for Patients with Breast Cancer
Read a blog post on the benefits of acupuncture for breast cancer patients
Ending Metastatic Breast Cancer for Everyone (EMBRACE) is the name of a research study being conducted at Dana-Farber Cancer Institute. This study began recruiting patients in 2009, with the aim of learning more about the biology of advanced breast cancer as well as the treatment experiences of patients living with it.
Each patient's progress is tracked by a study coordinator through medical records, and the information collected is used to help doctors understand more about the long-term journey of the metastatic breast cancer patients in this group. Investigators hope the study will bring them closer to finding a cure for metastatic breast cancer.
The study is not sponsored by drug companies, and patients are not required to be on any drug trials.
For more information on EMBRACE, please email email@example.com.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: